retatrutide or tesamorelin vs ...... both? #glp1 #fyp #foryoupage #tirzepatide #glp1community “Retatrutide vs Tesamorelin: Which Burns

Belal Molecular Pharmacology.2023

Weight is a very dynamic measurement

Physician oversight is the most important safety factor in peptide therapy and is a non-negotiable part of a responsible treatment plan

Patients who do not respond to GLP-1 therapy are becoming a growing concern in diabetes care, especially as GLP-1 receptor agonists continue to gain popularity for glycemic control and weight management

One report claims to have documented a mite penetrating an intact follicle wall

2 Recently, the potential applications of GLP-1 agonists beyond obesity and T2DM has garnered attention, with focus on their anti-inflammatory properties and pleotropic potential